Cibus, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| CBUS | CING | CRBU | CDXS | DTIL | MBX.TO | |
|---|---|---|---|---|---|---|
| Market cap | 94.77M | 66.31M | 47.64M | 118.27M | 226.84M | 39.72M |
| P/E (TTM) | — | — | — | — | 32.5 | — |
| Forward P/E | -2.0 | -5.2 | -0.5 | -3.4 | -4.4 | 14.5 |
| Price/book | 6.4 | 2.7 | 0.5 | 3.0 | 4.4 | 1.6 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −13.31% | +23.56% | −79.25% | −49.77% | +26.09% | +20.00% |
| Today | +8.77% | −3.39% | −3.27% | 0.00% | +16.50% | −3.33% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All CBUS news ›Cibus Tec 2026 Opens in Parma: 1,300 Exhibitors and 3,000 Top Buyers Make Food Tech's Biggest Case Yet
Organizers are calling it the most comprehensive and international edition in the event's history. For operators, manufacturers and procurement leaders, it's a four-day snapshot of the technology supply chain that quietly decides what…
MustGrow and Bayer advance mustard-based biocontrol in Europe, the Middle East, and Africa
Disseminated on behalf of: MustGrow Biologics Corp. Looking ahead, Bayer leads regulatory and market development, with further milestone payments tied to future achievements. MustGrow estimates the upfront payment, milestone payments, and…
Cibus (NASDAQ:CBUS) Stock Rating Lowered by Wall Street Zen
Posted by Kim Johansen on Oct 19th, 2026 Cibus (NASDAQ:CBUS – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued to clients and investors on…
More from 1 other outlet
Cibus and Crystal Crop Protection Team Up to Improve India’s Mustard Crop
Collaboration pairs Cibus’ platform for improving a plant’s own genes with Crystal Crop’s mustard varieties and its reach across India, with the goal of putting better-performing seed in growers’ hands in a fraction of the time of…
Nordea cuts Pandox and Cibus to hold
Nordea has cut its recommendation for hotel property company Pandox and real estate company Cibus to hold from buy.For Pandox, the bank expects a period of balance-sheet consolidation, as net debt to... Nordea has cut its recommendation…
They recommend buying in pressured high-yield Cibus
Business newspaper Dagens industri is once again recommending buying shares in real estate company Cibus, according to an analysis published under the Week's Stock column.Behind the recommendation is... Business newspaper Dagens industri…
Cibus Nordic Real Estate AB Stock (CIBUS) - Quote Nasdaq Stockholm
Cibus Nordic Real Estate AB (publ) is a Sweden-based company engaged in the real estate investment and management industry. The Company focuses on a pure play grocery-anchored real estate strategy, acquiring and managing properties leased…
Cibus Reports Landmark 2025 Year Driven by Commercialization and Regulatory Shifts
According to a transcript from The Motley Fool, Cibus, Inc. described 2025 as a landmark year, marked by a convergence of technology leadership, commercialization progress, scale, and regulatory momentum. The company stated it has shifted…
Nordea downgrades Cibus to hold (buy)
Nordea downgrades Cibus to hold ... Cibus Nordic Real Estate AB Real Estate Development & Operations Nordea downgrades Cibus to hold (buy)
Jefferies lowers price target for Cibus to SEK 130 (155), reiterates hold
www.marketscreener.com Cibus Nordic Real Estate AB Real Estate Development & Operations Jefferies lowers price target for Cibus to SEK 130 (155), reiterates hold
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com7
- agrospectrumindia.com3
- bnnbloomberg.ca1
- fb101.com1
- indexbox.io1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 17 articles, not a forecast.